Compare tickers
Up to 5 tickers, ~30 metrics, weighted verdict. Best in green, worst in red.
Verdict
Weighted score 0-100 across 1 tickers · best in green
25
25
15
20
15
Total: 100 · normalized in scoring
#1
GILD
score 50.0
Weakest momentum with 13.7% three-month decline drags overall score despite balanced metrics across all other categories.
value 50growth 50quality 50momentum 50sentiment 50
GILD
Gilead Sciences, Inc.
$127.57
-2.69%
GILD
Gilead Sciences, Inc.
$127.57
-2.69%
Snapshot
Price
127.57
Day %
-2.69
1M %
-3.1
3M %
-13.7
YTD %
4.91
Market cap
158387077120.0
ADV ($)
779031717.136383
Beta
0.332
Tao zone
Current zone
Pullback
Dist 21-EMA %
-3.77
Dist ATR (σ)
-1.49
Tao grade
—
Confluence
2
Valuation
P/E (ttm)
17.356462
P/E (fwd)
13.308851
P/S
5.3264422
EV/EBITDA
11.877
P/B
6.7379704
FCF yield
0.0501
PEG
2.14
Growth
Revenue yoy
0.044
EPS yoy
0.548
FCF yoy
—
Quality
Gross margin
0.79367995
Operating margin
0.39282
Net margin
0.30993
ROE
0.4336
ROA
0.13292
Debt / Equity
0.95
Interest cov.
10.57
Technicals
RSI(14)
38.0
MACD signal
neutral
vs 50-DMA
-5.3
vs 200-DMA
-0.92
vs 52w high
-18.9
HV-30
24.3
Sentiment
Analyst rec
1.64516
Target upside
23.72
Insider buy-sell 90d
—
Risk
Short interest
1.87
Days to cover
3.82
Next earnings
2026-08-06
Full GILD dashboard →